Sajjeev Jagannathan

1.1k total citations
22 papers, 735 citations indexed

About

Sajjeev Jagannathan is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Sajjeev Jagannathan has authored 22 papers receiving a total of 735 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Epidemiology. Recurrent topics in Sajjeev Jagannathan's work include Ubiquitin and proteasome pathways (8 papers), Protein Degradation and Inhibitors (5 papers) and Cancer Mechanisms and Therapy (3 papers). Sajjeev Jagannathan is often cited by papers focused on Ubiquitin and proteasome pathways (8 papers), Protein Degradation and Inhibitors (5 papers) and Cancer Mechanisms and Therapy (3 papers). Sajjeev Jagannathan collaborates with scholars based in United States, Egypt and Netherlands. Sajjeev Jagannathan's co-authors include James J. Driscoll, Ehsan Malek, Nikhil Vad, Artem Barski, Masashi Yukawa, Kenneth C. Anderson, Andrey Kartashov, Matthew T. Weirauch, Xiaoting Chen and Sivakumar Vallabhapurapu and has published in prestigious journals such as The Journal of Experimental Medicine, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Sajjeev Jagannathan

21 papers receiving 732 citations

Peers

Countries citing papers authored by Sajjeev Jagannathan

Since Specialization

Citations

This map shows the geographic impact of Sajjeev Jagannathan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sajjeev Jagannathan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sajjeev Jagannathan more than expected).

Fields of papers citing papers by Sajjeev Jagannathan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sajjeev Jagannathan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sajjeev Jagannathan. The network helps show where Sajjeev Jagannathan may publish in the future.

Co-authorship network of co-authors of Sajjeev Jagannathan

This figure shows the co-authorship network connecting the top 25 collaborators of Sajjeev Jagannathan. A scholar is included among the top collaborators of Sajjeev Jagannathan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sajjeev Jagannathan. Sajjeev Jagannathan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Abnormal Peyer patch development and B-cell gut homing drive IgA deficiency in Kabuki syndrome 2019 ·Journal of Allergy and Clinical Immunology ·Genay Pilarowski, (unknown), Li Zhang, Joel S. Benjamin, Ke Liu, Sajjeev Jagannathan, (unknown), (unknown), Artem Barski, Andrew Lindsley, Hans T. Björnsson	16
2	AP-1 activity induced by co-stimulation is required for chromatin opening during T cell activation 2019 ·The Journal of Experimental Medicine ·Masashi Yukawa, Sajjeev Jagannathan, (unknown), Andrey Kartashov, Xiaoting Chen, Matthew T. Weirauch, Artem Barski	106
3	AP-1 transcription factor remodels chromatin during T cell activation. 2018 ·The Journal of Immunology ·Artem Barski, Masashi Yukawa, Sajjeev Jagannathan, Andrey Kartashov, Xiaoting Chen, (unknown)	2
4	FOXF1 transcription factor promotes lung regeneration after partial pneumonectomy 2017 ·Scientific Reports ·Craig Bolte, (unknown), Xiaomeng Ren, Sajjeev Jagannathan, Artem Barski, Tanya V. Kalin, Vladimir V. Kalinichenko	51
5	Practicing pediatrician’s perspective on the immunization schedules: a short survey 2017 ·International Journal of Contemporary Pediatrics ·Sajjeev Jagannathan, (unknown), (unknown)	1
6	Psychosocial Problems Associated with Transfusion Dependent Thalassemia in a Tribal Population 2016 ·Pediatric Oncall ·(unknown), Sajjeev Jagannathan, (unknown), (unknown), (unknown)	2
7	Pharmacogenomics and chemical library screens reveal a novel SCFSKP2 inhibitor that overcomes Bortezomib resistance in multiple myeloma 2016 ·Leukemia ·Ehsan Malek, (unknown), Sajjeev Jagannathan, Nikhil Vad, Rebekah Karns, Anil G. Jegga, Annemiek Broyl, Mark van Duin, Pieter Sonneveld, Francesca Cottini, Kenneth C. Anderson, James J. Driscoll	48
8	CD28 co-stimulatory signaling and AP-1 transcription factor are involved in the establishment of open chromatin during T cell activation. 2016 ·The Journal of Immunology ·Masashi Yukawa, Sajjeev Jagannathan, Andrey Kartashov, Artem Barski	1
9	Pharmacologic screens reveal metformin that suppresses GRP78-dependent autophagy to enhance the anti-myeloma effect of bortezomib 2015 ·Leukemia ·Sajjeev Jagannathan, (unknown), Ehsan Malek, Nikhil Vad, Tahir Latif, Kenneth C. Anderson, James J. Driscoll	86
10	Abstract 4242: Metformin suppresses GRP78-dependent PI3-Kinase activity in clonogenic side population to enhance the anti-myeloma benefit of bortezomib 2015 ·Cancer Research ·James J. Driscoll, Sajjeev Jagannathan, (unknown), Nikhil Vad, Ehsan Malek	1
11	Abstract 153: Long non-coding RNAs deregulated in Multiple Myeloma impact therapeutic response to proteasome inhibitors 2015 ·Cancer Research ·Ehsan Malek, Rebekah Karns, Anil G. Jegga, Sajjeev Jagannathan, Nikhil Vad, (unknown), James J. Driscoll	1
12	Purification of heat labile toxin fromBordetella pertussisvaccine strain 134 employed indigenous technology 2015 ·SHILAP Revista de lepidopterología ·(unknown), Sajjeev Jagannathan, (unknown), (unknown), (unknown), (unknown), (unknown)	1
13	MiR-29b replacement inhibits proteasomes and disrupts aggresome+autophagosome formation to enhance the antimyeloma benefit of bortezomib 2014 ·Leukemia ·Sajjeev Jagannathan, Nikhil Vad, Sivakumar Vallabhapurapu, K C Anderson, James J. Driscoll	71
14	TM-03 * THE HSP90 INHIBITOR GANETESPIB IS AN EFFECTIVE THERAPY FOR GLIOBLASTOMA THAT BLOCKS EGFR-DRIVEN TUMOR GROWTH 2014 ·Neuro-Oncology ·James J. Driscoll, Nikhil Vad, Sajjeev Jagannathan	1
15	Molecular chaperone GRP78 enhances aggresome delivery to autophagosomes to promote drug resistance in multiple myeloma 2014 ·Oncotarget ·(unknown), Sajjeev Jagannathan, Ehsan Malek, Douaa Sayed, (unknown), (unknown), (unknown), James J. Driscoll	70
16	Correlation of long non-coding RNA expression with metastasis, drug resistance and clinical outcome in cancer 2014 ·Oncotarget ·Ehsan Malek, Sajjeev Jagannathan, James J. Driscoll	153
17	SC-31 * RATIONAL DESIGN OF A PI3-KINASE/mTOR INHIBITOR CYTOTOXIC TO BRAIN CANCER STEM CELLS UNDER HYPOXIA 2014 ·Neuro-Oncology ·Nikhil Vad, Sajjeev Jagannathan, (unknown), (unknown), James J. Driscoll	1
18	The brain microenvironment negatively regulates miRNA-768-3p to promote K-ras expression and lung cancer metastasis 2013 ·Scientific Reports ·(unknown), (unknown), Sajjeev Jagannathan, Kazutaka Sumita, Atsuo T. Sasaki, Bruce J. Aronow, Ronald E. Warnick, Sean Lawler, James J. Driscoll	32
19	MicroRNA theragnostics for the clinical management of multiple myeloma 2013 ·Leukemia ·(unknown), (unknown), Sajjeev Jagannathan, E. Anaissie, James J. Driscoll	53
20	Cullin-1 Controls The Clinical and Cellular response to Bortezomib Through NF-Kb Pathway Activation In Myeloma 2013 ·Blood ·James J. Driscoll, Elias Anaissie, Sajjeev Jagannathan	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact